Exosome Technologies Market Projected to Expand at a Steady CAGR Over the Forecast Period 2018-2026

Exosomes are extracellular vehicles produced by most of the cells. These are present in various body fluids and usually contain RNA and specific set of proteins. Exosomes play an important role intercellular communication. These can transfer molecules from one cell to another. Exosomes are being tested for therapeutic applications such as biomarkers, drug delivery systems, and therapies for diseases such as cancer and cardiovascular diseases. An article published by NCBI stated that exosomes have immunotherapeutic applications or can act as a drug delivery system for targeted therapies with drugs and biomolecules. This is due to their ability to selectively express proteins. Additionally, various studies have shown the potential applications of exosomes in drug and nucleic acid delivery, biomarkers, and anticancer vaccines.

Report Summary: https://www.transparencymarketresearch.com/exosome-technologies-market.html

Increase in awareness about exosome technologies, rise in prevalence of chronic disorders such as cancer and cardiovascular diseases, improved health care infrastructure, rise in R&D spending, technological advancements, surge in investment by major players in the development of treatments, rich product pipeline, and increase in government initiatives are the major drivers of the global exosome technologies market. However, lack of skilled professionals and stringent regulatory procedures are projected to act as major restraints of the global market.

The global exosome technologies market can be segmented based on biomolecule type, application, end-user, and region. In terms of biomolecule type, the global market can be classified into non-coding RNAs, mRNA, proteins / peptides, DNA fragments, and lipids. The non-coding RNAs segment dominated the market in 2018, and the trend is projected to continue during the forecast period. Growth of the segment is attributed to wide use of RNAs in the development for therapeutics and diagnostics for various diseases. Based on application, the global exosome technologies market can be divided into drug discovery, drug delivery, oncology, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. The drug delivery segment dominated the market in 2018 and is expected to continue its dominance during the forecast period. This is attributed to increase in research initiatives for the development of exosome as drug delivery system. An article published by NCBI indicated that exosomes have shown significant potential in the delivery of drugs or biomolecules in cell therapy treatments. In terms of end-user, the global market can be categorized into health care providers, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment dominated the market in 2018 due to high preference for this channel of distribution. The segment is likely to sustain its leadership position from 2019 to 2027.

Obtain Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=65840

In terms of region, the global exosome technologies market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018 and is projected to constitute significant market share during the forecast period. The market in the region is anticipated to grow at a rapid pace due to increase in geriatric population, rise in prevalence of chronic diseases such as cancer and cardiovascular diseases, technological advancements, and surge in acceptance of these technologies in the region. The market in Asia Pacific is expected to expand at a high CAGR in the next few years, driven by technological advancements, increase in research spending, and improvement in health care infrastructure in developing countries.

Major players operating in the global exosome technologies market include Thermo Fisher Scientific, Inc., Danaher, Fujifilm, Lonza, Illumina, Inc., Qiagen, Takara Bio Company, Exocome Diagnostics, and ExoCan Healthcare Technologies Pvt. Ltd.

Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=65840

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com